Fingerprint
Dive into the research topics of 'Highlights from: The 29th Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 2006 - Bevacizumab combination regimens as first-line therapy of metastatic breast cancer: The NCCTG N0432 and XCALiBr trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically